Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 5
2005 3
2006 3
2007 2
2008 2
2009 1
2010 1
2012 5
2013 6
2014 5
2015 7
2016 6
2017 8
2018 6
2019 4
2020 9
2021 6
2022 7
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yoon soon chang (3 results)?
Recent advances in diagnostic technologies in lung cancer.
Park HJ, Lee SH, Chang YS. Park HJ, et al. Among authors: chang ys. Korean J Intern Med. 2020 Mar;35(2):257-268. doi: 10.3904/kjim.2020.030. Epub 2020 Feb 28. Korean J Intern Med. 2020. PMID: 32131569 Free PMC article. Review.
Context-aware single-cell multiome approach identified cell-type specific lung cancer susceptibility genes.
Long E, Yin J, Shin JH, Li Y, Kane A, Patel H, Luong T, Xia J, Han Y, Byun J, Zhang T, Zhao W, Landi MT, Rothman N, Lan Q, Chang YS, Yu F, Amos C, Shi J, Lee JG, Kim EY, Choi J. Long E, et al. Among authors: chang ys. bioRxiv [Preprint]. 2023 Sep 26:2023.09.25.559336. doi: 10.1101/2023.09.25.559336. bioRxiv. 2023. PMID: 37808664 Free PMC article. Preprint.
Outstanding Characteristics of Birt-Hogg-Dube Syndrome in Korea.
Park HJ, Choi YJ, Park CH, Kim TH, Lee SS, Moon DH, Lee KA, Lee SE, Park MS, Kim SY, Chang YS, Lee SJ, Jung JY, Lee JH, Lee SH, Kim T, Kim SR, Kim K, Byun MK. Park HJ, et al. Among authors: chang ys. Diagnostics (Basel). 2023 Jun 13;13(12):2047. doi: 10.3390/diagnostics13122047. Diagnostics (Basel). 2023. PMID: 37370942 Free PMC article.
New Targeted Therapy for Non-Small Cell Lung Cancer.
Chung EK, Yong SH, Lee EH, Kim EY, Chang YS, Lee SH. Chung EK, et al. Among authors: chang ys. Tuberc Respir Dis (Seoul). 2023 Jan;86(1):1-13. doi: 10.4046/trd.2022.0066. Epub 2022 Oct 5. Tuberc Respir Dis (Seoul). 2023. PMID: 36196556 Free PMC article.
Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study.
Kim T, Jang TW, Choi CM, Kim MH, Lee SY, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH, Oh HJ. Kim T, et al. Among authors: chang ys. Cancer Res Treat. 2023 Oct;55(4):1152-1170. doi: 10.4143/crt.2023.493. Epub 2023 May 19. Cancer Res Treat. 2023. PMID: 37218139 Free PMC article.
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors.
Kim J, Jang TW, Choi CM, Kim MH, Lee SY, Park CK, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH. Kim J, et al. Among authors: chang ys. Transl Lung Cancer Res. 2023 Jun 30;12(6):1197-1209. doi: 10.21037/tlcr-22-832. Epub 2023 Jun 12. Transl Lung Cancer Res. 2023. PMID: 37425421 Free PMC article.
96 results